Shin Foong Ngiow

Best Publications

• Classifying Cancers Based on T-cell Infiltration and PD-L1

  Michele W.L. Teng;Michele W.L. Teng;Shin Foong Ngiow;Antoni Ribas;Mark J. Smyth;Mark J. Smyth

  1547
  Citations

• TOX transcriptionally and epigenetically programs CD8 + T cell exhaustion

  Omar Khan;Josephine R. Giles;Sierra McDonald;Sasikanth Manne

  1508
  Citations

• Combination cancer immunotherapies tailored to the tumour microenvironment.

  Mark J. Smyth;Shin Foong Ngiow;Antoni Ribas;Michele W. L. Teng

  1018
  Citations

• Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms

  Jean-Christophe Beltra;Sasikanth Manne;Mohamed S. Abdel-Hakeem;Makoto Kurachi

  978
  Citations

• Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease

  Jing Liu;Jing Liu;Stephen J. Blake;Michelle C.R. Yong;Heidi Harjunpää;Heidi Harjunpää

  840
  Citations

• TCF-1-Centered Transcriptional Network Drives an Effector Versus Exhausted CD8 T Cell-Fate Decision

  Zeyu Chen;Zhicheng Ji;Shin Foong Ngiow;Sasikanth Manne

  664
  Citations

• Anti-TIM3 Antibody Promotes T Cell IFN-γ–Mediated Antitumor Immunity and Suppresses Established Tumors

  Shin Foong Ngiow;Bianca von Scheidt;Hisaya Akiba;Hideo Yagita

  664
  Citations

• Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells

  Yulong Gao;Yulong Gao;Fernando Souza-Fonseca-Guimaraes;Fernando Souza-Fonseca-Guimaraes;Fernando Souza-Fonseca-Guimaraes;Tobias Bald;Susanna S Ng;Susanna S Ng

  632
  Citations

• Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy.

  John Stagg;Sherene Loi;Upulie Divisekera;Shin Foong Ngiow

  548
  Citations

• Cancer immunoediting by the innate immune system in the absence of adaptive immunity

  Timothy O’Sullivan;Robert Saddawi-Konefka;William Vermi;Catherine M. Koebel

  405
  Citations

• Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses

  Arabella Young;Arabella Young;Shin Foong Ngiow;Shin Foong Ngiow;Deborah S. Barkauskas;Erin Sult

  390
  Citations

• TIM3+FOXP3+ regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer

  Kaori Sakuishi;Shin Foong Ngiow;Jenna M. Sullivan;Michele W. L. Teng

  363
  Citations

• A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment.

  Arabella Young;Arabella Young;Shin Foong Ngiow;Shin Foong Ngiow;Shin Foong Ngiow;Yulong Gao;Yulong Gao;Ann Marie Patch

  358
  Citations

• Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.

  Katjana Klages;Christian T. Mayer;Katharina Lahl;Christoph Loddenkemper

  313
  Citations

• Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

  Deborah A. Knight;Shin Foong Ngiow;Shin Foong Ngiow;Ming Li;Ming Li;Tiffany Parmenter;Tiffany Parmenter

  300
  Citations

• Shared and distinct biological circuits in effector, memory and exhausted CD8+ T cells revealed by temporal single-cell transcriptomics and epigenetics

  Unknown

  285
  Citations

• A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1

  Shin Foong Ngiow;Arabella Young;Arabella Young;Nicolas Jacquelot;Takahiro Yamazaki

  251
  Citations

• Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade

  Nicolas Jacquelot;Takahiro Yamazaki;Maria P. Roberti;Connie P.M. Duong

  239
  Citations

• Conditional Regulatory T-Cell Depletion Releases Adaptive Immunity Preventing Carcinogenesis and Suppressing Established Tumor Growth

  Michele W.L. Teng;Shin Foong Ngiow;Bianca von Scheidt;Nicole McLaughlin

  219
  Citations

• In vivo CD8+ T cell CRISPR screening reveals control by Fli1 in infection and cancer.

  Zeyu Chen;Eri Arai;Omar Khan;Zhen Zhang

  204
  Citations